Trials / Unknown
UnknownNCT03248336
Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children
Objective Assessment of Disparity Vergence After Treatment of Symptomatic Convergence Insufficiency (CI) in Children
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Salus University · Academic / Other
- Sex
- All
- Age
- 9 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to evaluate changes in objective measures of disparity vergence after office-based vergence/accommodative therapy (OBVAT) for convergence insufficiency (CI) in children 12-17 years old.
Detailed description
30 participants with normal binocular vision and 30 with CI will be recruited for this prospective study. All participants with CI will be treated with 12 weeks of office-based vergence/accommodative therapy. The primary outcome measure will be the average peak velocity for 4° symmetrical convergence steps. Other objective outcome measures of disparity vergence will be time to peak velocity, latency, and accuracy. Changes in clinical measures \[near point of convergence (NPC), positive fusional vergence at near (PFV)\] and symptoms will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | office-based vergence/accommodative therapy | one -to-one treatment by a trained therapists. The subject is asked to perform 5-6 therapy procedures during a 60 minute therapy session. The subject is also asked to perform 15 minutes per day of home-based therapy. |
Timeline
- Start date
- 2018-09-02
- Primary completion
- 2022-09-01
- Completion
- 2022-12-01
- First posted
- 2017-08-14
- Last updated
- 2020-10-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03248336. Inclusion in this directory is not an endorsement.